EGFR-Mutant Lung Cancer
1 competing product in clinical development for EGFR-Mutant Lung Cancer.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| erlotinib | Astellas Pharma | Phase 1 | Completed | 29 |
1 competing product in clinical development for EGFR-Mutant Lung Cancer.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| erlotinib | Astellas Pharma | Phase 1 | Completed | 29 |